fluorodeoxyglucose f18 has been researched along with Macrophage Activation Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, SS; Hwang, SH; Jung, SM; Lee, SW; Park, YB; Song, JJ; Yun, M | 1 |
| Ju, JH; Kim, HY; Kim, JM; Kwok, SK; Park, GS; Park, KS; Park, SH | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Macrophage Activation Syndrome
| Article | Year |
|---|---|
The clinical utility of splenic fluorodeoxyglucose uptake for diagnosis and prognosis in patients with macrophage activation syndrome.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Macrophage Activation Syndrome; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sepsis; Spleen | 2017 |
Macrophage activation syndrome resistant to medical therapy in a patient with systemic lupus erythematosus and its remission with splenectomy.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Multimodal Imaging; Positron-Emission Tomography; Pregnancy; Pregnancy Complications; Splenectomy; Tomography, X-Ray Computed | 2013 |